keyword
https://read.qxmd.com/read/38649410/targeted-accurate-rna-consensus-sequencing-tarc-seq-reveals-mechanisms-of-replication-error-affecting-sars-cov-2-divergence
#1
JOURNAL ARTICLE
Catherine C Bradley, Chen Wang, Alasdair J E Gordon, Alice X Wen, Pamela N Luna, Matthew B Cooke, Brendan F Kohrn, Scott R Kennedy, Vasanthi Avadhanula, Pedro A Piedra, Olivier Lichtarge, Chad A Shaw, Shannon E Ronca, Christophe Herman
RNA viruses, like SARS-CoV-2, depend on their RNA-dependent RNA polymerases (RdRp) for replication, which is error prone. Monitoring replication errors is crucial for understanding the virus's evolution. Current methods lack the precision to detect rare de novo RNA mutations, particularly in low-input samples such as those from patients. Here we introduce a targeted accurate RNA consensus sequencing method (tARC-seq) to accurately determine the mutation frequency and types in SARS-CoV-2, both in cell culture and clinical samples...
April 22, 2024: Nature Microbiology
https://read.qxmd.com/read/38638997/four-port-tri-circular-ring-mimo-antenna-with-wide-band-characteristics-for-future-5g-and-mmwave-applications
#2
JOURNAL ARTICLE
Mehr E Munir, Moustafa M Nasralla, Maged Abdullah Esmail
MIMO (Multiple-Input-Multiple-Output) antenna systems are promising for fifth-generation (5G) networks, offering lower latency and higher data rates. These systems utilize millimeter-wave (mmWave) frequency bands for efficient transmission and reception of multiple data simultaneously, enhancing overall efficiency and performance. This article presents a compact size, wide band tri-circular ring mmWave MIMO antenna with suitable performance characteristics for next-generation communication systems. The MIMO system consists of a tri-circular ring patch with slots on a ground plane...
April 30, 2024: Heliyon
https://read.qxmd.com/read/38617323/the-oocyte-microenvironment-is-altered-in-adolescents-compared-to-oocyte-donors
#3
Dilan Gokyer, Sophia Akinboro, Luhan T Zhou, Anna Kleinhans, Monica M Laronda, Francesca E Duncan, Joan K Riley, Kara N Goldman, Elnur Babayev
STUDY QUESTION: Are the molecular signatures of cumulus cells (CCs) and follicular fluid (FF) of adolescents undergoing fertility preservation differ from that of reproductively adult oocyte donors? SUMMARY ANSWER: The microenvironment immediately surrounding the oocyte, including the CCs and FF, is altered in adolescents undergoing fertility preservation compared to oocyte donors. WHAT IS KNOWN ALREADY: Adolescents experience a period of subfecundity following menarche...
April 6, 2024: bioRxiv
https://read.qxmd.com/read/38596079/a-compact-and-efficiently-designed-two-port-mimo-antenna-for-n78-48-5g-applications
#4
JOURNAL ARTICLE
Manumula Srinubabu, Nuthakki Venkata Rajasekhar
A tightly packed irregular polygon with a distinctive protruding strip, specifically tailored for the N78/48 application, enhances a highly compact and effectively designed two-port MIMO (multiple-input, multiple-output) antenna. Its dimensions measure 20x31.5 × 1.6 mm3, with εr being 4.4 of FR-4 substrate, and it impressively delivers an extensive impedance bandwidth (Sxx  < -10 dB) spanning the 3.25-3.85 GHz range. The design incorporates a MIMO antenna with closely spaced elements, merely 1...
April 15, 2024: Heliyon
https://read.qxmd.com/read/38579729/inflammatory-and-subtype-dependent-serum-protein-signatures-predict-survival-beyond-the-ctdna-in-aggressive-b-cell-lymphomas
#5
JOURNAL ARTICLE
Maare Arffman, Leo Meriranta, Matias Autio, Harald Holte, Judit Jørgensen, Peter Brown, Sirkku Jyrkkiö, Mats Jerkeman, Kristina Drott, Øystein Fluge, Magnus Björkholm, Marja-Liisa Karjalainen-Lindsberg, Klaus Beiske, Mette Ølgod Pedersen, Suvi-Katri Leivonen, Sirpa Leppä
BACKGROUND: Biological heterogeneity of large B cell lymphomas (LBCLs) is poorly captured by current prognostic tools, hampering optimal treatment decisions. METHODS: We dissected the levels of 1,463 serum proteins in a uniformly treated trial cohort of 109 patients with high-risk primary LBCL (ClinicalTrials.gov: NCT01325194) and correlated the profiles with molecular data from tumor tissue and circulating tumor DNA (ctDNA) together with clinical data. FINDINGS: We discovered clinically and biologically relevant associations beyond established clinical estimates and ctDNA...
April 2, 2024: Med
https://read.qxmd.com/read/38563683/targeting-il-13-with-tralokinumab-normalizes-type-2-inflammation-in-atopic-dermatitis-both-early-and-at-2%C3%A2-years
#6
JOURNAL ARTICLE
Emma Guttman-Yassky, Kenji Kabashima, Delphine Staumont-Salle, Walter K Nahm, Sylvia Pauser, Joel Correa Da Rosa, Britta Cathrina Martel, Daniel Elenius Madsen, Mads Røpke, Petra Arlert, Louise Steffensen, Andrew Blauvelt, Kristian Reich
BACKGROUND: Tralokinumab is a monoclonal antibody that specifically neutralizes interleukin (IL)-13, a key driver of skin inflammation and barrier abnormalities in atopic dermatitis (AD). This study evaluated early and 2-year impacts of IL-13 neutralization on skin and serum biomarkers following tralokinumab treatment in adults with moderate-to-severe AD. METHODS: Skin biopsies and blood samples were evaluated from a subset of patients enrolled in the Phase 3 ECZTRA 1 (NCT03131648) and the long-term extension ECZTEND (NCT03587805) trials...
April 2, 2024: Allergy
https://read.qxmd.com/read/38558806/integrated-plasma-metabolomic-and-cytokine-analysis-reveals-a-distinct-immunometabolic-signature-in-atopic-dermatitis
#7
JOURNAL ARTICLE
Emily Z Ma, Junwen Deng, Varsha Parthasarathy, Kevin K Lee, Thomas Pritchard, Shenghao Guo, Cissy Zhang, Madan M Kwatra, Anne Le, Shawn G Kwatra
IMPORTANCE: Disease models for atopic dermatitis (AD) have primarily focused on understanding underlying environmental, immunologic, and genetic etiologies. However, the role of metabolic mechanisms in AD remains understudied. OBJECTIVE: To investigate the circulating blood metabolomic and cytokine profile of AD as compared to healthy control patients. DESIGN: This study collected plasma from 20 atopic dermatitis with moderate-to-severe itch (score of ≥5 on the itch Numeric Rating Scale and IGA score ≥3) and 24 healthy control patients...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38545854/safety-pharmacokinetics-and-pharmacodynamics-of-anti-il-4r%C3%AE-antibody-shr-1819-in-healthy-subjects-a-randomized-controlled-phase-i-study
#8
JOURNAL ARTICLE
Na Li, Sepehr Shakib, Weilin Qian, Xiaoyan Yao, Puyuan Li, Tsz Keung Nip, Xiaoyan Bai, Kai Shen
SHR-1819 is a novel anti-IL-4Rα monoclonal antibody currently under clinical development for use in patients with type 2 inflammatory diseases. In this randomized, double-blind, placebo-controlled, single-dose escalation phase I trial, we evaluated the safety, tolerability, pharmacokinetics, and pharmacodynamics of SHR-1819 in healthy subjects. Subjects received a single subcutaneous injection of SHR-1819 or placebo, with dose escalation starting at 60 mg and subsequently increasing to 120, 240, 360, and 720 mg...
April 2024: Clinical and Translational Science
https://read.qxmd.com/read/38541664/magnolol-reduces-atopic-dermatitis-like-symptoms-in-balb-c-mice
#9
JOURNAL ARTICLE
Ju-Hyun Lee, Dong-Soon Im
In traditional Korean medicines, Magnolia officinalis is commonly included for the remedy of atopic dermatitis, and magnolol is a major constituent of Magnolia officinalis . Its pharmacological effects include anti-inflammatory, hepatoprotective, and antioxidant effects. Using BALB/c mice repeatedly exposed to 1-chloro-2,4-dinitrobenzene (DNCB), magnolol was evaluated in atopic dermatitis-like lesions. Administration of magnolol (10 mg/kg, intraperitoneal injection) markedly relieved the skin lesion severity including cracking, edema, erythema, and excoriation, and significantly inhibited the increase in IgE levels in the peripheral blood...
March 5, 2024: Life
https://read.qxmd.com/read/38531691/blockade-of-il-13-signaling-improves-skin-barrier-function-and-biology-in-patients-with-moderate-to-severe-atopic-dermatitis
#10
JOURNAL ARTICLE
Nicole Sander, Dora Stölzl, Melina Fonfara, Jan Hartmann, Inken Harder, Ina Suhrkamp, Ivone Jakaša, Ellen van den Bogaard, Ivonne van Vlijmen-Willems, Silke Szymczak, Elke Rodriguez, Sascha Gerdes, Stephan Weidinger
BACKGROUND: Interleukin (IL)-13 is a key driver of inflammation and barrier dysfunction in atopic dermatitis (AD). While there is robust evidence that tralokinumab, a monoclonal antibody neutralizing IL-13, reduces inflammation and clinical disease activity, less is known about its effects on barrier function. OBJECTIVES: To characterize effects of tralokinumab treatment on skin barrier function. METHODS: Transepidermal water loss (TEWL), stratum corneum hydration (SCH), natural moisturizing factor (NMF) content, histopathological characteristics, biomarker expression and microbiome composition were evaluated in lesional, non-lesional, and sodium lauryl sulfate (SLS)-irritated skin of 16 AD patients over the course of 16 weeks of tralokinumab treatment...
March 26, 2024: British Journal of Dermatology
https://read.qxmd.com/read/38514190/inflammation-biomarkers-in-the-intracranial-blood-are-associated-with-outcome-in-patients-with-ischemic-stroke
#11
JOURNAL ARTICLE
Cyril Dargazanli, Marine Blaquière, Marinette Moynier, Frédéric de Bock, Julien Labreuche, Adrien Ter Schiphorst, Imad Derraz, Răzvan Alexandru Radu, Gregory Gascou, Pierre Henri Lefevre, Francesca Rapido, Julien Fendeleur, Caroline Arquizan, Romain Bourcier, Philippe Marin, Paolo Machi, Federico Cagnazzo, Christophe Hirtz, Vincent Costalat, Nicola Marchi
BACKGROUND: Performing endovascular treatment (EVT) in patients with acute ischemic stroke (AIS) allows a port of entry for intracranial biological sampling. OBJECTIVE: To test the hypothesis that specific immune players are molecular contributors to disease, outcome biomarkers, and potential targets for modifying AIS. METHODS: We examined 75 subjects presenting with large vessel occlusion of the anterior circulation and undergoing EVT. Intracranial blood samples were obtained by microcatheter aspiration, as positioned for stent deployment...
March 21, 2024: Journal of Neurointerventional Surgery
https://read.qxmd.com/read/38508346/a-composite-immune-and-vascular-stress-marker-in-patients-newly-diagnosed-with-bipolar-disorder-and-their-unaffected-first-degree-relatives
#12
JOURNAL ARTICLE
Klara Coello, Helle Holstad Pedersen, Klaus Munkholm, Hanne Lie Kjærstad, Sharleny Stanislaus, Sisse Rye Ostrowski, Maria Faurholt-Jepsen, Kamilla Woznica Miskowiak, Ruth Frikke-Schmidt, Maj Vinberg, Claus Thorn Ekstrøm, Julie Lyng Forman, Lars Vedel Kessing
AIMS: Substantial evidence emphasizes immune dysregulation in patients with bipolar disorder (BD). However, whether immune dysregulation is present already in the early illness stages of BD or even precedes development of BD is largely unknown. In this study we compared immune and vascular stress markers in patients newly diagnosed with BD, their unaffected first-degree relatives (UR) and healthy control individuals (HC) and investigated the ability a composite immune and vascular stress marker to discriminate between the three groups of participants...
March 19, 2024: Brain, Behavior, and Immunity
https://read.qxmd.com/read/38492337/fucosterol-isolated-from-sargassum-horneri-attenuates-allergic-responses-in-immunoglobulin-e-bovine-serum-albumin-stimulated-mast-cells-and-passive-cutaneous-anaphylaxis-in-mice
#13
JOURNAL ARTICLE
Arachchige Maheshika Kumari Jayasinghe, Hye-Won Yang, Kirinde Gedara Isuru Sandanuwan Kirindage, Kyungsook Jung, Jun-Geon Je, Lei Wang, Kil-Nam Kim, Ginnae Ahn
Allergic diseases have become a serious problem worldwide and occur when the immune system overreacts to stimuli. Sargassum horneri is an edible marine brown alga with pharmacological relevance in treating various allergy-related conditions. Therefore, this study aimed to investigate the effect of fucosterol (FST) isolated from S. horneri on immunoglobulin E(IgE)/bovine serum albumin (BSA)-stimulated allergic reactions in mouse bone marrow-derived cultured mast cells (BMCMCs) and passive cutaneous anaphylaxis (PCA) in BALB/c mice...
March 15, 2024: International Immunopharmacology
https://read.qxmd.com/read/38490296/ursodeoxycholic-acid-alleviates-atopic-dermatitis-associated-inflammatory-responses-in-hacat-and-rbl-2h3-cells-and-dncb-dfe-treated-mice
#14
JOURNAL ARTICLE
Eom Ji Kim, Hoyeon Park, Eun-Young Kim, Do Kyung Kim, Hyuk-Sang Jung, Youngjoo Sohn
AIMS: Ursodeoxycholic acid (UDCA) is a hydrophilic dihydroxy bile acid used for cholestatic liver disease and exhibits antioxidant, antitumor, and anti-inflammatory effects. However, its potential effects on atopic dermatitis (AD) have not been elucidated. This study aimed to evaluate the efficacy of UDCA in inhibiting the inflammatory response and alleviating lesions in AD-like mice. MAIN METHODS: To investigate the efficacy of UDCA in AD-like inflammatory responses, tumor necrosis factor-alpha (TNF-α)- and interferon-gamma (IFN-γ)-stimulated HaCaT cells and anti-dinitrophenyl immunoglobulin E (DNP-IgE)- and human serum albumin (HSA)-stimulated RBL-2H3 cells were used to investigate the levels of inflammatory factors and their mechanisms...
March 13, 2024: Life Sciences
https://read.qxmd.com/read/38450766/changes-in-the-composition-of-molecular-species-of-covalently-bound-and-free-ceramides-eos-and-their-correlation-with-disease-severity-in-atopic-dermatitis
#15
JOURNAL ARTICLE
A Kondo, Y Takenaka, A Fujiwara, S Takahashi, M Kitade-Miyayama, M Morifuji, M Kawashima, N Ishiguro
Ceramides are major constituents of stratum corneum (SC) intercellular lipids involved in skin barrier function. The ratio of molecular species of ceramides and their correlation with disease severity was examined in patients with atopic dermatitis (AD). Thirty-eight patients with AD and 32 healthy controls (HCs) were assessed for transepidermal water loss, SC collection and clinical assessment. The ceramide content of different molecular species in the samples was quantified using high-performance liquid chromatography coupled with tandem mass spectrometry...
March 2024: Experimental Dermatology
https://read.qxmd.com/read/38436589/predictive-and-prognostic-biomarkers-in-patients-with-mycosis-fungoides-and-s%C3%A3-zary-syndrome-bio-muse-study-protocol-for-a-translational-study
#16
JOURNAL ARTICLE
Emma Belfrage, Sara Ek, Åsa Johansson, Hanna Brauner, Andreas Sonesson, Kristina Drott
BACKGROUND: Cutaneous T-cell lymphoma (CTCL) is a rare group of lymphomas that primarily affects the skin. Mycosis fungoides (MF) is the most common form of CTCL and Sézary syndrome (SS) is more infrequent. Early stages (IA-IIA) have a favorable prognosis, while advanced stages (IIB-IVB) have a worse prognosis. Around 25% of patients with early stages of disease will progress to advanced stages. Malignant skin-infiltrating T-cells in CTCL are accompanied by infiltrates of non-malignant T-cells and other immune cells that produce cytokines that modulate the inflammation...
February 9, 2024: JMIR Research Protocols
https://read.qxmd.com/read/38421042/stratum-corneum-and-microbial-biomarkers-precede-and-characterize-childhood-atopic-dermatitis
#17
JOURNAL ARTICLE
Melina Fonfara, Jan Hartmann, Dora Stölzl, Nicole Sander, Inken Harder, Elke Rodriguez, Matthias Hübenthal, Carsten Mazur, Sebastian Kerzel, Michael Kabesch, Jochen Schmitt, Hila Emmert, Ina Suhrkamp, Stephan Weidinger
BACKGROUND: Atopic dermatitis (AD) is the most common paediatric inflammatory skin disease. There are currently no robust biomarkers that could reliably predict its manifestation, and on the molecular level, it is less well characterized than adult AD. OBJECTIVES: This study aimed to extend previous findings and provide evidence for distinct changes of the epidermal proteome and microbiome preceding the onset of AD as well as characterizing early AD. METHODS: We longitudinally analysed epidermal biomarker levels and microbial profiles in a cohort of 50 neonates at high risk for AD, who had participated in a randomized controlled trial on early emollient use for AD prevention...
February 29, 2024: Journal of the European Academy of Dermatology and Venereology: JEADV
https://read.qxmd.com/read/38409467/pyromeconic-acid-enriched-erigeron-annuus-water-extract-as-a-cosmetic-ingredient-for-itch-relief-and-anti-inflammatory-activity
#18
JOURNAL ARTICLE
Minkyoung Kang, Minji Kang, Tae Hee Kim, Seong Un Jeong, Sangnam Oh
Erigeron annuus (EA), traditionally used to treat disorders such as diabetes and enteritis, contains a variety of chemicals, including caffeic acid, flavonoids, and coumarins, providing antifungal and antioxidative benefits. However, the ingredients of each part of the EA vary widely, and there are few reports on the functionality of water extracts in skin inflammation and barrier protection. We assessed the therapeutic properties of the extract of EA without roots (EEA) and its primary ingredient, pyromeconic acid (PA), focusing on their antihistamine, anti-inflammatory, and antioxidative capabilities using HMC-1(human mast cells) and human keratinocytes (HaCaT cells)...
February 26, 2024: Scientific Reports
https://read.qxmd.com/read/38375189/a-bispecific-tetravalent-antibody-targeting-inflammatory-and-pruritogenic-pathways-in-atopic-dermatitis
#19
JOURNAL ARTICLE
Julia Tietz, Tea Gunde, Stefan Warmuth, Christopher Weinert, Matthias Brock, Alexandre Simonin, Christian Hess, Maria Johansson, Fabio Spiga, Simone Muntwiler, Belinda Wickihalder, Dana Mahler, Dania Diem, Julia Zeberer, Robin Heiz, Naomi Flückiger, Noriko Shiraishi, Yoshihide Miyake, Nobuaki Takahashi, Markus Fehrholz, Marta Bertolini, Peter Lichtlen, David Urech, Daniel Snell
Inhibition of IL-4/IL-13 signaling has dramatically improved the treatment of atopic dermatitis (AD). However, in many patients, clinical responses are slow to develop and remain modest. Indeed, some symptoms of AD are dependent on IL-31, which is only partially reduced by IL-4/IL-13 inhibition. Thus, there is an unmet need for AD treatments that concomitantly block IL-4/IL-13 and IL-31 pathways. We engineered NM26-2198, a bispecific tetravalent antibody designed to accomplish this task. In reporter cell lines, NM26-2198 concomitantly inhibited IL-4/IL-13 and IL-31 signaling with a potency comparable with that of the combination of an anti-IL-4Rα antibody (dupilumab) and an anti-IL-31 antibody (BMS-981164)...
March 2024: JID innovations
https://read.qxmd.com/read/38336018/artificial-intelligence-serving-pre-surgical-digital-implant-planning-a-scoping-review
#20
REVIEW
Bahaaeldeen M Elgarba, Rocharles Cavalcante Fontenele, Mihai Tarce, Reinhilde Jacobs
OBJECTIVES: To conduct a scoping review focusing on artificial intelligence (AI) applications in presurgical dental implant planning. Additionally, to assess the automation degree of clinically available pre-surgical implant planning software. DATA AND SOURCES: A systematic electronic literature search was performed in five databases (PubMed, Embase, Web of Science, Cochrane Library, and Scopus), along with exploring gray literature web-based resources until November 2023...
February 7, 2024: Journal of Dentistry
keyword
keyword
75609
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.